Sage Therapeutics Inc. buy DomRuinart
Start price
16.06.21
/
50%
€46.95
Target price
16.06.22
€75.00
Performance (%)
2.24%
End price
28.06.21
€48.00
Summary
This prediction ended on 28.06.21 with a price of €48.00. The BUY prediction by DomRuinart finished with a performance of 2.24%. DomRuinart has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | 7.594% | 7.594% | -70.648% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% |
According to DomRuinart what are the pros and cons of Sage Therapeutics Inc. for the foreseeable future?
Pros
Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
Strong uniques
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Sage Therapeutics Inc. diskutieren
SAGE: institutional ownership 90,73%...Insider Käufe in Millionenhöhe in den letzten Tagen...no brainer, würde ich meinen...
In the thread Trading Sage Therapeutics Inc.
Stopped prediction by DomRuinart for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.00
28.06.21
28.06.21
€75.00
28.06.22
28.06.22
-2.98%
12.07.21
12.07.21
Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
